Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00321750Phase 2Terminated
Phase 2, randomised, double-blind trial of Pimecrolimus vehicle + topical corticosteroid in oral lichen planus (OLP) (2 arms), sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoints: 12-point clinical score at 4 weeks and Blood level of pimecrolimus at Day 28. Started Dec 2004; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00321750.